Substrate and Inhibitor Specificity of the Type II p21-Activated Kinase, PAK6

Jia Gao; Byung Hak Ha; Hua Jane Lou; Elizabeth M. Morse; Rong Zhang; David A. Calderwood; Benjamin E. Turk; Titus J. Boggon

doi:10.1371/journal.pone.0077818

Loading metrics

Open Access

Peer-reviewed

Research Article

Substrate and Inhibitor Specificity of the Type II p21-Activated Kinase, PAK6

Jia Gao,

Affiliations State Key Laboratory for Conservation and Utilization of Subtropical Agro-biosciences, The Key Laboratory of Ministry of Education for Microbial and Plant Genetic Engineering, and College of Life Science and Technology, Guangxi University, Nanning, Guangxi, China, Department of Pharmacology, Yale University School of Medicine, New Haven, Connecticut, United States of America
⨯
Byung Hak Ha,

Affiliation Department of Pharmacology, Yale University School of Medicine, New Haven, Connecticut, United States of America
⨯
Hua Jane Lou,

Affiliation Department of Pharmacology, Yale University School of Medicine, New Haven, Connecticut, United States of America
⨯
Elizabeth M. Morse,

Affiliations Department of Pharmacology, Yale University School of Medicine, New Haven, Connecticut, United States of America, Department of Cell Biology, Yale University School of Medicine, New Haven, Connecticut, United States of America
⨯
Rong Zhang,

Affiliation Department of Pharmacology, Yale University School of Medicine, New Haven, Connecticut, United States of America
⨯
David A. Calderwood,

Affiliations Department of Pharmacology, Yale University School of Medicine, New Haven, Connecticut, United States of America, Department of Cell Biology, Yale University School of Medicine, New Haven, Connecticut, United States of America, Yale Cancer Center, Yale University School of Medicine, New Haven, Connecticut, United States of America
⨯
Benjamin E. Turk,

Affiliations Department of Pharmacology, Yale University School of Medicine, New Haven, Connecticut, United States of America, Yale Cancer Center, Yale University School of Medicine, New Haven, Connecticut, United States of America
⨯
Titus J. Boggon

* E-mail: titus.boggon@yale.edu

Affiliations Department of Pharmacology, Yale University School of Medicine, New Haven, Connecticut, United States of America, Yale Cancer Center, Yale University School of Medicine, New Haven, Connecticut, United States of America
⨯

Substrate and Inhibitor Specificity of the Type II p21-Activated Kinase, PAK6

Jia Gao,
Byung Hak Ha,
Hua Jane Lou,
Elizabeth M. Morse,
Rong Zhang,
David A. Calderwood,
Benjamin E. Turk,
Titus J. Boggon

Published: October 28, 2013
https://doi.org/10.1371/journal.pone.0077818

Reader Comments (0)

Post a new comment on this article

Subject Areas
?

For more information about PLOS Subject Areas, click here.
We want your feedback. Do these Subject Areas make sense for this article? Click the target next to the incorrect Subject Area and let us know. Thanks for your help!

Phosphorylation
Is the Subject Area "Phosphorylation" applicable to this article?

Thanks for your feedback.
Crystal structure
Is the Subject Area "Crystal structure" applicable to this article?

Thanks for your feedback.
Small molecules
Is the Subject Area "Small molecules" applicable to this article?

Thanks for your feedback.
Molecular structure
Is the Subject Area "Molecular structure" applicable to this article?

Thanks for your feedback.
Prostate cancer
Is the Subject Area "Prostate cancer" applicable to this article?

Thanks for your feedback.
Peptide libraries
Is the Subject Area "Peptide libraries" applicable to this article?

Thanks for your feedback.
Androgens
Is the Subject Area "Androgens" applicable to this article?

Thanks for your feedback.
Electron density
Is the Subject Area "Electron density" applicable to this article?

Thanks for your feedback.